Literature DB >> 19176362

Expression pattern of XBP1(S) in human B-cell lymphomas.

Lorena Maestre1, Reuben Tooze, Marta Cañamero, Santiago Montes-Moreno, Rocio Ramos, Gina Doody, May Boll, Sharon Barrans, Sara Baena, Miguel Angel Piris, Giovanna Roncador.   

Abstract

The transcription factor XBP1 (X-box-binding protein 1) is essential for plasma cell (PC) differentiation and immunoglobulin secretion. XBP1 is widely expressed, but its activity is precisely controlled by mRNA splicing in response to endoplasmic reticulum (ER) stress. It is the active form of XBP1, XBP1(S), which is required for PC differentiation. The relationship between XBP1(S) expression and PC differentiation in human tissue and its expression in hematologic malignancies has eluded assessment. With a novel antibody, we now define XBP1(S) expression in a large series of normal and neoplastic lymphoid tissues. We establish that XBP1(S) provides a specific marker of advanced plasma differentiation and in lymphoid malignancies is restricted to PC-derived neoplasms and plasmablastic diffuse large B-cell lymphomas. XBP1(S) expression delineates heterogeneity amongst plasmablastic diffuse large B-cell lymphomas, identifying a distinct tumor sub-group. Furthermore, our results establish a direct and practical means of assessing ER stress in human tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176362      PMCID: PMC2649342          DOI: 10.3324/haematol.2008.001156

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Plasma cell differentiation requires the transcription factor XBP-1.

Authors:  A M Reimold; N N Iwakoshi; J Manis; P Vallabhajosyula; E Szomolanyi-Tsuda; E M Gravallese; D Friend; M J Grusby; F Alt; L H Glimcher
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA.

Authors:  Marcella Calfon; Huiqing Zeng; Fumihiko Urano; Jeffery H Till; Stevan R Hubbard; Heather P Harding; Scott G Clark; David Ron
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

3.  Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1.

Authors:  Neal N Iwakoshi; Ann-Hwee Lee; Prasanth Vallabhajosyula; Kevin L Otipoby; Klaus Rajewsky; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 4.  The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response.

Authors:  Neal N Iwakoshi; Ann-Hwee Lee; Laurie H Glimcher
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988

5.  Generation of a new monoclonal antibody against MALT1 by genetic immunization.

Authors:  Lorena Maestre; Lorena Fontan; Jose Angel Martinez-Climent; Jose Francisco Garcia; Juan Cruz Cigudosa; Giovanna Roncador
Journal:  Hybridoma (Larchmt)       Date:  2007-04

6.  XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation.

Authors:  A L Shaffer; Miriam Shapiro-Shelef; Neal N Iwakoshi; Ann-Hwee Lee; Shu-Bing Qian; Hong Zhao; Xin Yu; Liming Yang; Bruce K Tan; Andreas Rosenwald; Elaine M Hurt; Emmanuel Petroulakis; Nahum Sonenberg; Jonathan W Yewdell; Kathryn Calame; Laurie H Glimcher; Louis M Staudt
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

7.  Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.

Authors:  Kuo-I Lin; Cristina Angelin-Duclos; Tracy C Kuo; Kathryn Calame
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Proteasome inhibitors disrupt the unfolded protein response in myeloma cells.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Kenneth C Anderson; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

9.  Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Authors:  Lluís Colomo; Florence Loong; Susana Rives; Stefania Pittaluga; Antonio Martínez; Armando López-Guillermo; Jesús Ojanguren; Vicens Romagosa; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

10.  Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1.

Authors:  A M Reimold; P D Ponath; Y S Li; R R Hardy; C S David; J L Strominger; L H Glimcher
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  15 in total

1.  Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.

Authors:  J Chapman; A J Gentles; V Sujoy; F Vega; C I Dumur; T L Blevins; L Bernal-Mizrachi; M Mosunjac; A Pimentel; D Zhu; I S Lossos
Journal:  Leukemia       Date:  2015-04-24       Impact factor: 11.528

2.  Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.

Authors:  Santiago Montes-Moreno; Nerea Martinez-Magunacelaya; Tomás Zecchini-Barrese; Sonia Gonzalez de Villambrosía; Emma Linares; Tamara Ranchal; María Rodriguez-Pinilla; Ana Batlle; Laura Cereceda-Company; Jose Bernardo Revert-Arce; Carmen Almaraz; Miguel A Piris
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

Review 3.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies.

Authors:  B Luo; A S Lee
Journal:  Oncogene       Date:  2012-04-16       Impact factor: 9.867

4.  Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.

Authors:  Santiago Montes-Moreno; Ana-Rosa Gonzalez-Medina; Socorro-María Rodriguez-Pinilla; Lorena Maestre; Lydia Sanchez-Verde; Giovanna Roncador; Manuela Mollejo; Juan F García; Javier Menarguez; Carlos Montalbán; M Carmen Ruiz-Marcellan; Eulogio Conde; Miguel A Piris
Journal:  Haematologica       Date:  2010-04-23       Impact factor: 9.941

5.  Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype.

Authors:  Samuel E J Preston; Audrey Emond; Filippa Pettersson; Daphné Dupéré-Richer; Madelyn Jean Abraham; Alberto Riva; Mena Kinal; Ryan N Rys; Nathalie A Johnson; Koren K Mann; Sonia V Del Rincón; Jonathan D Licht; Wilson H Miller
Journal:  Mol Cancer Ther       Date:  2022-04-01       Impact factor: 6.009

6.  Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Miaoxia He; Changjing Zuo; Jianjun Wang; Jianmin Liu; Binghua Jiao; Jianmin Zheng; Zailong Cai
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

7.  Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.

Authors:  Ming Hu; Jose Trevino; Lijun Yang; Dengfeng Cao; Xiuli Liu; Jinping Lai
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

8.  Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.

Authors:  Sergey Krysov; Andrew J Steele; Vania Coelho; Adam Linley; Marina Sanchez Hidalgo; Matthew Carter; Kathleen N Potter; Benjamin Kennedy; Andrew S Duncombe; Margaret Ashton-Key; Francesco Forconi; Freda K Stevenson; Graham Packham
Journal:  Blood       Date:  2014-08-28       Impact factor: 22.113

9.  X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.

Authors:  Imogen Yi-Chun Lai; Paul J Farrell; Paul Kellam
Journal:  J Gen Virol       Date:  2010-10-27       Impact factor: 3.891

10.  TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes.

Authors:  Sinisa Savic; Lylia Ouboussad; Laura J Dickie; Janina Geiler; Chi Wong; Gina M Doody; Sarah M Churchman; Frederique Ponchel; Paul Emery; Graham P Cook; Maya H Buch; Reuben M Tooze; Michael F McDermott
Journal:  J Autoimmun       Date:  2013-12-31       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.